Tenders

Leki Biologiczne II

Otwarty
Termin składania ofert
Pozostało 10 dni
Marzec 13, 2026
Szczegóły umowy
Kategoria
Dostawy
Numer Referencyjny
305811
Wartość
€235,000
Lokalizacja
Estonia
Published
Luty 12, 2026
Kod CPV
Kryteria oceny
Bid cost100%
Harmonogram Projektu

Ogłoszenie przetargu

Luty 12, 2026

Termin składania pytań

Marzec 06, 2026

Termin składania ofert

Marzec 13, 2026

Otwarcie ofert

Marzec 13, 2026

Prawdopodobieństwo wygranejPRO
🔒
Uaktualnij do Professional
Zobacz szacowane prawdopodobieństwo wygranej na podstawie danych historycznych.
Uaktualnij do wersji profesjonalnej →
Analityka zamawiającegoPRO
🔒
Odblokuj analitykę zamawiającego
Zobacz wzorce wydatków, preferowane procedury i więcej.
Uaktualnij do wersji profesjonalnej →
Analiza sektoraPRO
🔒
Odblokuj analizę sektora
Zobacz średnie ceny zwycięskie, poziomy konkurencji i trendy rynkowe.
Uaktualnij do wersji profesjonalnej →
Budget
€235,000
Duration
Not specified
Lokalizacja
Estonia
Type
Dostawy
83
Ocena Jakości/100
Doskonała
Benchmark rynkowy
Śr. cena wygrywająca
€92,792
Śr. liczba ofert
2.2
Konkurencja
Niska
Zwycięzcy MŚP
86%
3,220 przeanalizowanych zamówień

Oryginalny Opis Przetargu

Celem zamówienia publicznego jest zawarcie umowy ramowej na zakup leków biologicznych. Bardziej szczegółowy opis przedmiotu zamówienia publicznego znajduje się w dokumencie „Załącznik 1. Specyfikacja techniczna”. W wyniku zamówienia publicznego zostanie zawarta umowa ramowa z jednym dostawcą dla każdej części zamówienia publicznego na okres 12 miesięcy. Odrębne umowy nie będą podpisywane na podstawie umowy ramowej, lecz realizacja umowy ramowej będzie odbywać się na podstawie zamówień. Cena jednostkowa leku przedstawiona w ofercie jest ważna przez cały okres obowiązywania umowy ramowej.
Electronic Submission

Analiza ryzyka

Zaloguj się, aby korzystać z analizy ryzyka.

Zaloguj się

Strategia wygrywania

Zaloguj się, aby uzyskać dostęp do rekomendacji strategii wygrywania.

Zaloguj się

Konkurenci

Ulepsz plan, aby zobaczyć, które firmy prawdopodobnie złożą ofertę w tym przetargu, na podstawie historycznych danych zamówień publicznych.

Zaloguj się

Wymagania i Kwalifikacje

16 wymagań w 5 kategoriach

Składanie (6)
Obowiązkowe (1)
Zgodność (3)
Techniczne (3)
Finansowe (3)
SUBMISSION REQUIREMENTS6
--Submit a completed European Single Procurement Document (ESPD).
--For joint bidders, a power of attorney must be submitted.
--Follow the procedure for declaring business secrets.
MANDATORY EXCLUSION GROUNDS1
--The bidder must not have any grounds for exclusion established by the contracting authority, as described in the ESPD.
ELIGIBILITY REQUIREMENTS3
--The bidder must fulfill the qualification conditions established by the contracting authority, as described in the ESPD.
--The bidder must comply with EU sanctions against the Russian Federation.
--If the bidder relies on the resources of another entity to meet qualification criteria, that entity must provide consent and commit to fulfilling the relevant contractual obligations.
TECHNICAL CAPABILITY REQUIREMENTS3
--The offered biological medicines must comply with the technical specifications, including active ingredients, pharmaceutical forms, strengths, and packaging, as stipulated in the Technical Description (Annex 1).
--Delivery conditions must meet the requirements, including transport, original packaging, and minimum shelf life, as described in the Technical Description (Annex 1).
--Technical specifications for the offered biological medicines must be submitted using Form Annex 3.
FINANCIAL REQUIREMENTS3
--The bid price (excluding VAT) is the sole evaluation criterion, with the lowest price receiving the maximum score.
--The bidder must accept the payment terms described in the draft framework agreement (Annex 2).
--Unit prices must be submitted excluding VAT and must be valid for the entire contract period, using Form Annex 3.

Podgląd wymagań

Zarejestruj się, aby zobaczyć pełne wymagania i analizę

Dokumenty

9 dokumentów dostępnych z podsumowaniami AI

VastavustingimusedPDF
305811_vastavustingimused.pdf -- 17.3 KB

This document outlines tender compliance conditions, including adherence to EU sanctions against the Russian Federation, the requirement for a joint bidders' authorization if applicable, and procedures for declaring business secrets.

Lisa 3. Pakutavate kaupade spetsifikatsioon ja maksumuse vormXLS
Lisa 3 Pakutavate kaupade spetsifikatsioon ja... -- 12.0 KB

This document is a form where bidders must provide the technical specifications and VAT-exclusive unit prices of the biological medicines offered, which will be valid throughout the contract period.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
305811_hindamiskriteeriumid.pdf -- 7.2 KB

This document details the tender evaluation methodology, specifying that the bid cost (excluding VAT) is the sole criterion, with the lowest price receiving the maximum points.

Hankepass täiendatavate selgitustegaPDF
305811_hankepass_taiendavate_selgitustega.pdf -- 63.9 KB

This document is an explanatory Hankepass (ESPD) outlining the contracting authority's qualification conditions and exclusion grounds, intended for review rather than direct submission.

Juhend pakkujaleDOC
Juhend pakkujale.docx -- 44.8 KB

This document is a guide for tenderers participating in the open procurement procedure "Biological medicines II," outlining the tender parts and estimated costs.

Lisa 1. Tehniline kirjeldusDOC
Lisa 1 Tehniline kirjeldus.docx -- 33.6 KB

This document outlines the technical specifications for biological medicines, including active ingredients, dosage forms, strengths, and packaging, along with delivery conditions such as transport, original packaging, and minimum shelf life.

Lisa 2. Raamlepingu projektDOC
Lisa 2 Raamlepingu projekt.docx -- 30.3 KB

This is a draft framework agreement for the sale and transport of biological medicines, detailing the contract's subject, validity, and payment terms, providing an overview of future contractual obligations.

Lisa 4. Ühispakkujate volikiriDOC
Lisa 4 Ühispakkujate volikiri.docx -- 18.5 KB

This document is a power of attorney template for joint tenderers, outlining their joint and several liability and authorizing one partner to submit the tender and manage the resulting contract on behalf of the consortium.

Lisa 5. Teise ettevõtja nõusolek tema vahenditele tuginemiseksDOC
Lisa 5 Teise ettevõtja nõusolek tema vahendit... -- 17.8 KB

This document is a consent form where a third party confirms that the tenderer may rely on its resources to meet the qualification conditions for the "Bioloogilised ravimid II" public procurement and commits to fulfilling the relevant contractual obligations.

Podgląd dokumentów

Zarejestruj się, aby zobaczyć podsumowania i analizę dokumentów

83
Doskonała

Ocena Jakości Przetargu

This tender for biological medicines is well-structured and clear, demonstrating strong legal compliance and fairness through transparent criteria and e-procurement. While comprehensive, it lacks explicit sustainability considerations and has minor data inconsistencies.

Szczegółowy Wynik

Zgodność z przepisami85/100

The tender appears largely compliant with national and EU regulations, clearly defining the procedure type and CPV codes. Deadlines are reasonable, and EU sanctions compliance is explicitly required. The 'Negotiation Allowed' characteristic for an 'A' (Open) procedure is a minor ambiguity, as open procedures are typically non-negotiable.

The characteristic 'Negotiation Allowed' is listed for an 'A' (Open) procedure, which is typically non-negotiable, creating a minor procedural ambiguity.
Przejrzystość90/100

The tender description is clear, and requirements are well-documented across various annexes. Evaluation criteria (lowest price) and performance conditions are explicitly stated, making the tender easy to understand for potential bidders. AI-extracted requirements are comprehensive and accurate.

Kompletność85/100

All essential information, including title, organization, reference, estimated value, and duration (12 months for the framework agreement), is provided. The tender includes 10 relevant documents detailing technical specifications, contract terms, and submission forms. The NUTS code is missing, which is a minor omission.

NUTS code is not provided.
Uczciwość90/100

The tender promotes fairness through a disclosed estimated value, reasonable submission deadlines, and objective evaluation criteria (lowest price). E-procurement is enabled, ensuring equal access, and requirements appear generic, not tailored to a specific company.

Praktyczność80/100

Electronic submission and e-procurement are fully supported, enhancing practicality. Financing information and duration are specified within the documents. The exact contract start date is not explicitly stated but is typically determined upon award.

The exact contract start date is not explicitly stated.
Spójność danych85/100

Key fields are mostly populated, and dates are logical. There are no reported disputes or suspensions. The minor inconsistency regarding 'Negotiation Allowed' for an 'A' procedure and the 'Value Classified: Yes' alongside a disclosed estimated value are noted but do not significantly hinder overall consistency.

Minor inconsistency between 'Procedure: A' (Open) and 'Negotiation Allowed' characteristic.
Slight ambiguity with 'Value Classified: Yes' despite an estimated value being disclosed.
Zrównoważony rozwój30/100

The tender does not explicitly incorporate green procurement, social aspects, or innovation focus. While this is common for medical supplies where product efficacy and safety are paramount, it represents a missed opportunity to align with broader sustainability goals.

No explicit sustainability criteria (green, social, innovation) are included.

Mocne strony

Clear and comprehensive requirements with detailed annexes.
Objective and transparent evaluation criteria (lowest price).
Full support for electronic submission and e-procurement.
Reasonable submission deadline and disclosed estimated value.
Compliance with EU sanctions explicitly required.

Wątpliwości

Lack of explicit sustainability, social, or innovation criteria.
Minor inconsistency regarding 'Negotiation Allowed' for an 'A' (Open) procedure.
NUTS code is missing from the basic information.
The exact contract start date is not explicitly stated.

Rekomendacje

1. Consider integrating sustainability criteria, such as environmentally friendly packaging or ethical sourcing, where applicable for biological medicines.
2. Clarify the 'Negotiation Allowed' characteristic in relation to the 'A' (Open) procedure type to avoid potential misinterpretations.
3. Provide the NUTS code for better geographical classification.

Podgląd oceny AI

Zarejestruj się, aby zobaczyć pełne wymagania i analizę

Pełna analiza oceny jakości
Szczegółowy rozkład ocen cząstkowych
Mocne strony i obawy – informacje
Rekomendacje strategiczne

Karta kredytowa nie jest wymagana • Konfiguracja w 2 minuty

Dodaj do pipeline'u